Çığır Biray Avcı

32PUBLICATIONS
73CO-AUTHORS
Molecular targetsBiofabricationTraditional Chinese medicine and treatmentsChemotherapyBiogeography and phylogeography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Aug 10, 2026
miR-640 Enhances Abemaciclib Sensitivity by Suppressing CDK Inhibitor Resistance-Associated Genes in Breast Cancer Cells.

|Jul 08, 2026
Microfluidic Biofabrication of a Hydrogel Vessel-Like Structure for Interrogating Tumor Cell Propagation in a Breast Cancer-on-a-Chip Model.

|Jun 07, 2026
Temozolomide and ruxolitinib combination modulates miRNA-associated regulatory networks in glioblastoma stem cells.

|Apr 21, 2026
Correction: The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells.

|Mar 04, 2026
BET inhibition enhances temozolomide sensitivity in cervical cancer cells through ALDH suppression and epigenetic reprogramming.

Kemal Eker, Maryam Sabour Takanlou, Leila Sabour Takanlou

|Jan 23, 2026
The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells.

Neslihan Pinar Ozates, Bakiye Goker Bagca, Aycan Asik

Pageof 6

Frequent Collaborators

8 joint publications

Bakiye Goker-Bagca

6 joint publications

Neslihan Pınar Özateş

5 joint publications

Cumhur Gunduz

4 joint publications

Aycan Asik